Overview

An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.

Status:
Terminated

Trial end date:
2020-03-16

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the adhesion of the test product when compared to the reference product following a single transdermal application.

Phase:

Phase 1

Details

Lead Sponsor:

Sandoz

Treatments:

Rotigotine